Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment with methotrexate.

Next Previous
Trial Profile

An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment with methotrexate.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rituximab (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Roche

Most Recent Events

  • 05 Dec 2011 Actual initiation date changed from Mar 2008 to Oct 2007 as reported by ClinicalTrials.gov.
  • 05 Dec 2011 Actual patient number is 20 according to ClinicalTrials.gov.
  • 18 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top